A New Approach for the Patient with Erectile Dysfunction

This symposium took place on 21st March 2015 (18.00–19.30) as part of the Annual European Association of Urology (EAU) Congress in Madrid, Spain

Chairperson: Ian Eardley1
Speakers: Hartmut Porst,2 Ignacio Moncada,3 Béatrice Cuzin,4 Ian Eardley1

1. St James’s University Hospital and Leeds General Infirmary, Leeds, UK
2. Private Institute for Urology, Andrology and Sexual Medicine, Hamburg, Germany
3. Hospital Sanitas La Zarzuela, Madrid, Spain
4. Hospices Civils of Lyon, Lyon, France

Disclosure: Ian Eardley is a consultant and speaker for Takeda, Menarini, Lilly, Pfizer, Sanofi, and Allergan. Hartmut Porst is a consultant, speaker and/or  investigator for Auxilium, Bayer Healthcare, Lilly Company,  and Menarini-Group. Ignacio Moncada is a consultant, speaker and/or investigator for Lilly, Recordati, and  Sobi. Béatrice Cuzin is consultant, speaker and/or investigator for Auxilium Pharmaceuticals, Inc (AUXL)/ Swedish Orphan Biovitrum AB (Sobi), Lilly, Laboratories Majorelle, Menarini, and Pierre Fabre.
Acknowledgements: Writing assistance was provided by Dr Ana Rodríguez de Ledesma, apothecom scopemedical Ltd.
Support: The symposium was jointly organised and funded by Casen Recordati, Laboratories Majorelle, Sandoz International GmbH, and Takeda UK Limited. All authors received honoraria for preparation and delivery of their presentations. The publication of this article was funded by Takeda UK Limited. The views and opinions expressed are those of the authors and not necessarily of Casen Recordati, Laboratories Majorelle, Sandoz International GmbH, or Takeda UK Limited.
Citation: EMJ Urol. 2015;3[2]:48–56.

Meeting Summary

This satellite symposium was held in two sessions. The first session was offered in a traditional format where invited experts reviewed and discussed the latest concepts and developments on the management of erectile dysfunction (ED). During the second session, experts discussed clinical cases from their  real-life practice in an interactive format, to facilitate discussions with the audience, and to provide participants with the most relevant aspects of ED. The symposium objectives were to review and discuss  the current status of the management of ED and treatment needs for patients with ED, and to explore  the latest evidence on the use of topical alprostadil cream (Vitaros®, Virirec®, Vytaros®)1 – who benefits the most?

Click here for PI.

Download (PDF, 174KB)

Comments are closed.